Navigation Links
GenOdyssee Receives Broad Product Applications Protection in EU for Founding Natural Evolution Technology
Date:10/24/2008

GenOdyssee Has Received Notice of Allowance of European Patent Application

Covering Its Core Natural Evolution Technology Invented in 2002, and Received Broad Product Applications Protection Rights to All Cytokine

Families

PARIS, October 24 /PRNewswire/ -- GenOdyssee (GO), a biotechnology company dedicated to the discovery and development of improved 'next generation' human protein therapeutics, announced today that it has received notice of allowance from the European Patent Office of its Patent Application no.3 785 733.1 (PCT/EP03/13965) covering its core founding drug discovery technology process entitled "Method For Providing Natural Therapeutic Agents With High Therapeutic Index" for applications to all therapeutic cytokine families.

The company pioneered the vision that natural evolution has created in the general population superior genetic variants of key human protein therapeutic drugs as compared to the first wave of reference protein therapeutic variants isolated and developed during the first biotech boom in the 80s, which currently constitute standard of care.

"We have always believed that our technology has wide potential in the industry for discovery of second generation products. Our IFN and EPO products have been granted IP in all major countries in which we filed a product patent application, including the EU and the USA. Our IP portfolio now extends to 53 patents and patent applications in more than 19 countries. Importantly, the European patent office has now granted our technology broad product protection rights across all cytokine families. The granting of such broad IP product rights is relatively unusual and has been achieved in this case because GenOdyssee successfully demonstrated successful application of its technology across multiple products in various cytokine families," said Dr. David Brown, senior executive advisor for science & bus dev to GenOdyssee.

"This
'/>"/>

SOURCE GenOdyssee SA
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
2. Alfacell Receives Going Concern Audit Opinion
3. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
4. NanoVibronix Receives FDA Clearance for its PainShield(TM) MD Device
5. PAREXEL Corporate Vice President Dr. Alberto Grignolo Receives Lifetime Achievement Award From Good Clinical Practice Journal
6. Medivation Receives Corporate Achievement Award From Huntingtons Disease Society of America
7. Bolder BioTechnology Receives $1.6 million NIH Grant to Continue Development of Multiple Sclerosis Drug
8. BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World
9. Althea Technologies Receives Fast Growth Honors: Deloitte Technology Fast 50 and San Diego Business Journal Fast 100 Awards for the Fifth Consecutive Year
10. POET Receives Additional $76 Million in Federal Funding For Commercialization of Cellulosic Ethanol
11. Imaging Diagnostic Systems Receives its First Order for its CT Laser Mammography System for Israel

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Four of the top 10 pharmaceutical... submissions to Health Canada. Datafarm’s an... 7th Canadian DIA Annual Meeting where Health Cana...panies may submit Hybrid eCTD regulatory submissio... no prior permission request. , ...
(Date:11/9/2009)... Product release is a research ind..., research facilities and research safety study da... Cedar Knolls, NJ (PRWEB) No... today that it has unveiled Pristima™ VM, an...rch facilities that track the use and care of vete...
(Date:11/9/2009)... LONDON, November 9 Following the ...S Food and Drug Administration (FDA), privately,ow...//www.davalinternational.com ) has been informed t...(R) has been awarded an Orphan-Drug,designation fo...ALS). , ALS, also known as Lou Gehrig,s d...
(Date:11/8/2009)...r 6, 2009 As global temperatures and energy costs...l be key to a sustainable future. An attractive ...udies published online in Genome Research ( www....structures of bioethanol-producing microorganisms,... developing new technologies needed to implement p...
Breaking Biology Technology:Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification 2Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2
...ution Agreement, GURGAON, India and PRINCETON, N....a wholly owned subsidiary of Ranbaxy,Laboratories ... several,agreements with AstraZeneca. Two of these...s. The third agreement pertains to Omeprazole 40mg...odipine ER capsules. All,of the agreements are spe...
...us, Inc.,today announced the appointment of Fisher...its new automated PLAC Test for the Hitachi, Hitac... to U.S. hospital clinical,laboratories. The new a...ood & Drug Administration (FDA) enabling the test ...rs., The PLAC Test is the only blood test cleared...
...asdaq: BNVI ) will present findings on the mechan...07 and BN108 at the American Association of,Cancer...ntion Center in San,Diego, CA, April 12 - 16, 2008...e pathway for cancer cell,apoptosis (cell death) i...a,Shtivelman, Director of Cancer Research at Biono...
Other Biology Technology:Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation 2Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation 3diaDexus Selects Fisher HealthCare to Sell New Automated PLAC(R) Test 2diaDexus Selects Fisher HealthCare to Sell New Automated PLAC(R) Test 3Bionovo to Present Recent Findings of BN107 and BN108, Its Anticancer Agents, at the American Association of Cancer Research 2
(Date:11/9/2009)...A, NOVEMBER 9, 2009 A nutritionist whose researc... to the federal Women, Infants and Children (WIC) ... Higgins Award for outstanding achievement in the ...ison, Ph.D., MNS, , a professor in the Department ...California, Los Angeles School of Public Health, w...
(Date:11/8/2009)...AYETTE, Ind. - Researchers at Purdue University ha... nerve fibers in spinal cord injuries using nano-s...ly after an accident. , The synthetic "copolymer...meters in diameter, or roughly 100 times smaller t...ers have been studying how to deliver drugs for ca...
(Date:11/8/2009)...- (Nov. 8, 2009) The loss of a gene through delet...ated with significant abnormalities in learning an...y Baylor College of Medicine ( www.bcm.edu ) in a ...ature Genetics . , "This research goes about 95 ...specific group of individuals to this gene," said ...
Breaking Biology News(10 mins):March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Developmental delay could stem from nicotinic receptor deletion 2MU study finds connection between evolution classroom learning 8764 1MU study finds connection between evolution classroom learning 8764 2Revitalized Village Sparkles in the North Country 48294 1Revitalized Village Sparkles in the North Country 48294 2Morphotek 28R 29 Inc Announces FDA Acceptance of Investigational New Drug Application for MORAb 004 a Monoclonal Antibody for the Treatment of Soli 48291 1Morphotek 28R 29 Inc Announces FDA Acceptance of Investigational New Drug Application for MORAb 004 a Monoclonal Antibody for the Treatment of Soli 48291 2Morphotek 28R 29 Inc Announces FDA Acceptance of Investigational New Drug Application for MORAb 004 a Monoclonal Antibody for the Treatment of Soli 48291 3
...rrent issue of CELL TRANSPLANTATION (Vol. 17:4) fe...king new ways to treat Parkinsons disease (PD), a ...ity, tremor and slowed physical movements related ...al ganglia of the brain, by using primate models t...ed cells. , One research team looked at the abili...
...and Technology (NIST) has developed Standard Refer... in folk medicine and now increasingly used in her...new materials to develop and test analytical metho...aterials for quality assurance of their measuremen...nce to address the use of bitter orange for health...
...l of Forest Research presents the preliminary find... landscape-scale experiments on how forest managem...The Blacks Mountain Interdisciplinary Research tea...versity, Oregon State University, U.C. Riverside, ...ciety scientists collaborating in research on larg...
Other Biology News:Neural cell transplants may help those with Parkinson's disease 2Neural cell transplants may help those with Parkinson's disease 3Bitter orange SRMs: Tools for product analysis/quality 2Pioneering landscape-scale research releases first findings 2
Calf Serum, Iron-Supplemented from Sigma-Aldrich
...NA Polymerase is a thermostable DNA polymerase der...ty at temperatures above 70°C, it was the fir...e predominant enzyme for that purpose. The enzyme ...ease activity, but lacks 3'--5' proofreading exonu...
Mouse Anti-Yersinia pestis F1 antigen Monoclonal Antibody, Unconjugated, Clone YPF19 from Abcam
...radient system uses three Adept CE 4100 high pres... in one microlitre increaments. The Adept CE 4200...System control and data processing is provided by ... unit, CE 4900., Column heater/chillers can be su...
Biology Products: